Skip to the page

Data / Form D filings / Chickadee Biomedicines, Inc.

Chickadee Biomedicines, Inc.: Form D filing

Chickadee Biomedicines, Inc., a biotechnology company in Boston, MA, filed a Form D with the SEC in 2026. The latest, on June 25, 2026, reports $150,000 sold of a $1 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
91 OAKMERE STREET, Boston, MA, 02132
Phone
(617) 302-2620
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2025
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2138882

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jun 25, 2026New notice$1,000,000$150,000$850,0001Jun 22, 2026sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Weining LuExecutive Officer, Director, Promoter
Mikael Goran DolstenExecutive Officer, Director, Promoter

Other biotechnology companies in Massachusetts that filed recently

Every Form D from the week of Jun 22, 2026 · All recent filings in Massachusetts · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Chickadee Biomedicines, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.